TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 EUR)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
559
|
476 | |
| Financial expenses |
32
|
0 | |
| Earnings before taxes |
346
|
328 | |
| EBITDA |
181
|
320 | |
| Total assets |
1,668
|
1,335 | |
| Current assets |
727
|
454 | |
| Current liabilities |
176
|
76 | |
| Equity capital |
1,407
|
1,179 | |
| - share capital |
5
|
5 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
84.4%
|
88.3% | |
| Turnover per employee |
280
|
238 | |
| Profit as a percentage of turnover |
61.9%
|
68.9% | |
| Return on assets (ROA) |
22.7%
|
24.6% | |
| Current ratio |
413.1%
|
597.4% | |
| Return on equity (ROE) |
24.6%
|
27.8% | |
| Change turnover |
115
|
24 | |
| Change turnover % |
8%
|
26%
|
5% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.